Skip to main content
. 2015 Sep 21;2015(9):CD006362. doi: 10.1002/14651858.CD006362.pub4

Nagaoka 1980.

Methods Double‐blind, head‐to‐head comparison, natural colds
Participants 222 adults, sex not reported for the subgroup of colds, 51 centres, outpatient departments of hospitals and clinics, URTI onset ≤ 2 days and fever ≤ 39 °C
Interventions 2 groups: fentiazac 300 mg/day and ibuprofen 600 mg/day for 3 days
Outcomes Moderate to marked improvement of FGIR was more frequent in the fenoprofen group than the placebo (P value < 0.05)
Notes No available data on adverse effects for the subgroup of common colds
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Comment: insufficient information about the sequence generation process
Allocation concealment (selection bias) Low risk "... randomisation process was done by two controllers and key codes were kept by controllers (in Japanese)"
Blinding (performance bias and detection bias) 
 All outcomes Low risk "... double‐blind, double‐dummy method...active drug and placebo were quite similar in shape (in Japanese)"
Comment: probably done
Incomplete outcome data (attrition bias) 
 All outcomes Low risk "243 out of 244 patients were analyzed after the elimination of 1 drop‐out case"
Comment: number of withdrawals was too small to make any important difference to the estimated intervention effect
Comment: probably done
Selective reporting (reporting bias) Unclear risk No protocol, no convincing text
Other bias Low risk The study appears to be free of other sources of bias